Hair Disorders Associated with Anticancer Agents
November 2013
TLDR Some cancer treatments cause different types of hair loss, but scalp cooling can help prevent it.
A decade ago, a study by Caroline Yeager and Elise A. Olsen from the Department of Dermatology, Duke University Medical Center, reviewed the types and amounts of hair loss associated with various anticancer agents. The study focused on three main types of hair abnormalities seen with chemotherapy-induced hair loss/alopecia (CIA): telogen effluvium, anagen effluvium, and abnormal hair growth. Cytotoxic chemotherapy traditionally caused either a telogen or anagen effluvium, while targeted therapies could also cause abnormal hair growth. The study also discussed potential measures to prevent or hasten the regrowth seen with CIA. Among the prophylactic treatment options, scalp cooling was the most extensively used and discussed treatment method for CIA, showing benefit in preventing hair loss. The development of quantitative grading scales for CIA was also noted, which could aid in evaluating possible interventions.
View this study on onlinelibrary.wiley.com →
Cited in this study
research Permanent chemotherapy-induced alopecia: Case report and review of the literature
Some chemotherapy can cause permanent hair loss.
research Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer
research Chemotherapy-Induced Alopecia
Scalp cooling might reduce hair loss from chemotherapy, but evidence is weak and other treatments are being tested.
research Trichomegaly of the eyelashes following treatment with cetuximab
Cetuximab can cause excessive eyelash growth.
research A Technique for Reconstruction of Eyebrows and Eyelashes
The document concludes that hair follicular unit transplantation is an effective method for eyebrow and eyelash reconstruction, with patients happy despite needing regular trimming.
research Permanent alopecia after cranial irradiation: Dose–response relationship
Higher doses of cranial irradiation are linked to permanent hair loss.
research A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Tempol is safe and may prevent hair loss from brain radiotherapy.
research Optimal Management of Hair Loss (Alopecia) in Children
Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.
research Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor
research Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice
Cyclosporin A helps damaged hair follicles regrow hair quickly.
research Permanent alopecia following chemotherapy and bone marrow transplantation
Chemotherapy and bone marrow transplant can cause permanent hair loss.
research A randomized trial of minoxidil in chemotherapy-induced alopecia
Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.
research Prevention of doxorubicin-induced alopedia by scalp hypothermia: relation to degree of cooling.
Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.
Related
research Baricitinib Results in Eyebrow and Eyelash Growth in Patients With Alopecia Areata Who Do Not Achieve 20% or Less Scalp Hair Loss
Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.
research Use of a Scalp Clarifying Shampoo in the Treatment of Lichen Planopilaris and Female Pattern Hair Loss
research Safety and Efficacy of Trimax-360 Serum in Healthy Adult Subjects with Mild to Moderate Alopecia of the Scalp
Trimax-360 Serum, when used for 98 days, safely and effectively improves hair growth, thickness, and density without any side effects.
research Hair loss (alopecia or baldness)
Baldness is often hereditary and linked to male hormones, becoming noticeable when half the hair is lost.